Inovio Pharmaceuticals, Inc.NASDAQ: INO

INOVIO to Participate in Upcoming Investor Conferences

· Issued by Inovio Pharmaceuticals, Inc. via PR Newswire

Summary by 6ix AI

INOVIO, a biotechnology company developing DNA medicines for HPV (human papillomavirus)-related diseases, cancer and infectious diseases, will take part in two investor conferences in London and New York, with webcasts of both sessions.

Key details

  • Jefferies Global Healthcare Conference in London: presentation on Wednesday, November 18 at 12:00 p.m. EST / 5:00 p.m. GMT.
  • Piper Sandler 38th Annual Healthcare Conference in New York: fireside chat on Tuesday, December 1 from 2:00-2:25 p.m. EST.
  • Replays of the presentations will be available for 90 days, and members of INOVIO's management team will also hold one-on-one meetings with investors during the conferences.

6ix AI wrote this summary from the release below and checked it against the release.

PLYMOUTH MEETING, Pa., Nov. 11, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a commercial-stage biotechnology company focused on developing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in the following investor conferences:

Jefferies Global Healthcare Conference in London
Date: Wednesday, November 18
Time: 12:00 p.m. EST / 5:00 p.m. GMT
Format: Presentation
Webcast: https://event.summitcast.com/view/avibSrFufLKeoLRAEgMxy6/e3gFZPzHNgoxtsxeAwXEr2

Piper Sandler 38th Annual Healthcare Conference in New York
Date: Tuesday, December 1
Time: 2:00-2:25 p.m. EST
Format: Fireside chat
Webcast: https://event.webcasts.com/starthere.jsp?ei=1782025&tp_key=9cacd40318

Replays of the presentations will be available for 90 days at the links above. During these conferences members of INOVIO's management team will also be conducting one-on-one meetings with investors.

About INOVIO
INOVIO is a commercial-stage biotechnology company focused on developing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that enable the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com and follow us on LinkedIn and X (formerly known as Twitter).

Contacts
Media: Josephine Galatioto - ICR Healthcare, [email protected]
Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505, [email protected]

SOURCE INOVIO Pharmaceuticals, Inc.

View original source (PR Newswire)Inovio Pharmaceuticals, Inc. on 6ix

In the deck

Story so far

Earlier from Inovio Pharmaceuticals

Later from Inovio Pharmaceuticals

All Inovio Pharmaceuticals news releases